Burlat, Kem B.
HRN: 22-81-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2023
CEFUROXIME 1.5GM (VIAL)
04/09/2023
04/09/2023
IV
1.5g IV Now Then Q8H
Q8
Incomplete Abortion
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes